Table 3_Efficacy and safety of transcutaneous electrical acupoint stimulation and acupress

Jiang Yuan's dataset contains results from a randomized clinical trial on 198 female breast cancer patients undergoing chemotherapy. The data, published on figshare in 2026, compares the effects of transcutaneous electrical acupoint stimulation (TEAS) and acupressure versus a control group over four chemotherapy cycles. It analyzes intervention effects on nausea, vomiting, sleep, anxiety, depression, and quality of life using generalized estimating equations.

Use Cases

• Compare the longitudinal efficacy of TEAS versus acupressure based on the described multi-cycle follow-up.
• Model the dynamic progression of chemotherapy-induced nausea and vomiting (CINV) risk based on the described time effect.
• Analyze intervention effects on psychosomatic symptoms like anxiety and depression based on the described primary outcomes.
• Assess the cumulative therapeutic effect of TEAS based on the described interaction effect in mid-to-late chemotherapy cycles.

Strengths

• Data is from a randomized clinical trial with 198 participants, providing a structured experimental basis.
• Analysis includes intention-to-treat and per-protocol set analyses, suggesting methodological rigor.
• Longitudinal follow-up over four chemotherapy cycles captures dynamic effects.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for specific modeling tasks.
• The dataset is very small at 27.8 KB, indicating limited scope, likely containing summary results rather than raw patient-level data.

Provenance

Source

figshare, author Jiang Yuan.

Collection Method

Data collected via a randomized clinical trial (ChiCTR2300077667) with simple randomization using R4.4.2.

Time Range

Temporal coverage of the trial is not specified, but data reflects four chemotherapy cycles.

Freshness

Last updated 2026-04-15 04:37:17; freshness should be verified.

Geography

Spatial coverage is not specified, but the trial was registered on a Chinese clinical trial registry.